Renaissance Capital logo

GNLX News

Renaissance Capital's January IPO Market Update

Genelux logo

Following the challenges of the prior year, the 2023 IPO market started off strong with the Renaissance IPO Index climbing 16%, more...read more

US IPO Weekly Recap: Oil and gas producer TXO leads a 4 IPO week

TXO

Four IPOs made it to market this past week, as several small deals delayed (BFRG, INTS, LRE, LSDI). Three companies joined the pipeline, including one filing to raise $100 million. TXO Energy Partners LP (TXO) led the week’s...read more

Solid tumor biotech Genelux prices IPO at $6 low end

Genelux logo

Genelux, a Phase 3 biotech developing oncolytic viral immunotherapies for solid tumors, raised $15 million by offering 2.5 million shares at $6, the low end of the range of $6 to $7. Genelux is developing a pipeline of oncolytic viral immunotherapies for...read more

US IPO Week Ahead: January closes out with a busy IPO calendar, led by energy company TXO

TXO

Eight companies are currently scheduled to go public in the week ahead, seven of which are eligible for inclusion in our IPO stats. If all seven qualifying deals price, it would be the busiest week for the US IPO market in over a year. The week’s lineup...read more